﻿<?xml version="1.0" encoding="UTF-8" ?>
<rdf:RDF xmlns:admin="http://webns.net/mvcb/" xmlns="http://purl.org/rss/1.0/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:prism="http://purl.org/rss/1.0/modules/prism/" xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:syn="http://purl.org/rss/1.0/modules/syndication/">
<channel rdf:about="http://medrxiv.org">
<admin:errorReportsTo rdf:resource="mailto:medrxiv@cshlpress.edu"/>
<title>medrxiv Subject Collection: Epidemiology</title>
<link>http://medrxiv.org</link>
<description>
This feed contains articles for medRxiv Subject Collection "Epidemiology"
</description>

<items>
<rdf:Seq>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.05.11.26352919v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.05.07.26350887v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.05.14.26353210v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.05.14.26353143v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.05.13.26351511v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.05.15.26347859v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.05.13.26353093v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.05.12.26353074v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.05.13.26353146v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.05.12.26353059v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.05.12.26352978v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.05.11.26352889v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.05.09.26352793v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.05.09.26352820v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.05.08.26352715v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.05.08.26352137v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.05.08.26352718v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.05.08.26352733v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.05.08.26352755v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.05.08.26352721v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.05.06.26352603v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.05.06.26352614v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.05.07.26352639v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.05.07.26352695v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.05.04.26352208v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.05.06.26352609v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.05.06.26352579v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.05.07.26352661v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.05.07.26352530v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.05.06.26352545v1?rss=1"/>
</rdf:Seq>
</items>
<prism:eIssn/>
<prism:publicationName>medrxiv</prism:publicationName>
<prism:issn/>

<image rdf:resource=""/>
</channel>
<image rdf:about="">
<title>medrxiv</title>
<url>https://www.medrxiv.org/sites/default/files/medrxiv_internal_logo.png</url>
<link>http://medrxiv.org</link>
</image>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.05.11.26352919v1?rss=1">
<title>
<![CDATA[
Baseline Data Collection of Persons with ID/DD by Housing Status: A Cross-Sectional Baseline Survey of Adults with Disabilities in Supported Independent and Family Living 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.05.11.26352919v1?rss=1
</link>
<description><![CDATA[
This report presents findings from a baseline cross sectional survey of autistic adults and adults with intellectual and developmental disabilities (IDD) connected to Our Stomping Ground (OSG), a nonprofit organization in northern Virginia committed to supported independent living. The survey was administered in 2022 and 2023 as the first wave of a planned longitudinal study, with the primary goal of establishing a comparable starting point between two groups: adults who were living, or preparing to live, independently in an OSG apartment building, and adults with disabilities who were continuing to live at home with family. A total of 76 adults completed the survey out of 98 potential participants. The two groups were well-matched at baseline across a wide range of characteristics, which is exactly what a sound longitudinal design requires. This comparability means that when follow up data are collected, any observed differences between the groups can be more confidently attributed to the experience of independent living rather than to pre-existing differences. These findings provide the empirical foundation for the longitudinal phase of this study and offer a meaningful snapshot of the health, well-being, and support needs of autistic adults and adults with IDD at a pivotal life stage.
]]></description>
<dc:creator><![CDATA[ Cleary, S. D. ]]></dc:creator>
<dc:date>2026-05-18</dc:date>
<dc:identifier>doi:10.64898/2026.05.11.26352919</dc:identifier>
<dc:title><![CDATA[Baseline Data Collection of Persons with ID/DD by Housing Status: A Cross-Sectional Baseline Survey of Adults with Disabilities in Supported Independent and Family Living]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-05-18</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.05.07.26350887v1?rss=1">
<title>
<![CDATA[
Genomic surveillance of a deeply sampled local population reveals age-specific drivers of RSV transmission 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.05.07.26350887v1?rss=1
</link>
<description><![CDATA[
Respiratory syncytial virus (RSV) disproportionately causes severe infections among infants and older adults, yet the key age group responsible for viral spread to other age groups remains poorly defined. While current immunization approaches effectively reduce disease severity among the most vulnerable, identifying the core drivers of infection is essential to effectively disrupt population-level transmission. By generating 910 whole-genome viral sequences of RSV from all age groups (<1 to 65+ years) in Connecticut, we identified that children aged 12-35 months are the primary drivers of viral transmission to other age groups. This group significantly shapes the genetic diversity of circulating strains. Furthermore, we found that RSV is introduced into the community through frequent and independent entries from other US regions throughout the year, rather than through a single explosive seasonal introduction or long-term local persistence. Ultimately, our findings justify prevention strategies that expand beyond reducing disease burden to actively prioritizing the reduction of transmission and infection.
]]></description>
<dc:creator><![CDATA[ Kwon, J., de Vries, E. M., Lemey, P., Li, K., Breban, M., Laing, K., Ferguson, D., Schulz, W. L., Oliveira, C. R., Bont, L. J., Pitzer, V. E., Weinberger, D. M., Grubaugh, N. D., Hill, V., Redmond, S. ]]></dc:creator>
<dc:date>2026-05-18</dc:date>
<dc:identifier>doi:10.64898/2026.05.07.26350887</dc:identifier>
<dc:title><![CDATA[Genomic surveillance of a deeply sampled local population reveals age-specific drivers of RSV transmission]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-05-18</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.05.14.26353210v1?rss=1">
<title>
<![CDATA[
Accounting for Uncertainty in the Null Benchmark in Two-Stage Phase II Trials 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.05.14.26353210v1?rss=1
</link>
<description><![CDATA[
Background Simon two-stage designs for binary endpoints and their time-to-event analogues, including the Kwak and Jung method, rely on a fixed null benchmark. Their Type I error control is valid only when that benchmark is correctly specified. In practice, historical benchmarks are often inconsistent due to small samples, population heterogeneity, changing eligibility criteria, and evolving standards of care. Even modest misspecifications can substantially inflate the Type I error rate, leading to costly advancement of ineffective treatments. Methods We propose the Interval-Null Robust (INR) two-stage design framework that accounts for uncertainty in the historical null benchmark. We define the null hypothesis as a plausible range of clinically uninteresting values: p[isin][p0L, p0U] for binary endpoints and {lambda}[isin][{lambda}0L, {lambda}0U] (or equivalent survival probabilities) for time-to-event endpoints. Type I error is controlled uniformly over the full null interval: sup{theta}[isin]{theta}0 Pr{theta}(Go) [&le;] . Under the monotonicity of the Go probability, the supremum occurs at the least favorable null configuration - p0U and {lambda}0L - but the design is not reduced to a point-null formulation. The interval defines the uncertainty set for error control and is used in selecting among feasible designs through robust criteria such as worst-case regret or minimal average expected sample size. Results Across representative planning scenarios for both endpoint types, classic designs calibrated to a single benchmark exhibit substantial Type I error inflation when the true null parameter exceeds the assumed planning value. INR designs maintain the nominal Type I error rate across the full null interval, directly addressing this vulnerability to benchmark misspecification. The robustness-efficiency trade-off can be managed through design constraints and robust optimization criteria while preserving uniform Type I error control. Conclusions INR two-stage designs offer a transparent framework for addressing historical control uncertainty in single-arm Phase II trials. By replacing reliance on a fixed benchmark assumption with a more realistic interval of clinically plausible null values, INR design reduces the risk of false-positive Go-decisions caused by benchmark misspecification. INR applies to both binary and time-to-event endpoints and is implemented in the open-source INRDesign R package and accompanying interactive Shiny app.
]]></description>
<dc:creator><![CDATA[ Irlmeier, R., Jin, Z., Ye, F. ]]></dc:creator>
<dc:date>2026-05-18</dc:date>
<dc:identifier>doi:10.64898/2026.05.14.26353210</dc:identifier>
<dc:title><![CDATA[Accounting for Uncertainty in the Null Benchmark in Two-Stage Phase II Trials]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-05-18</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.05.14.26353143v1?rss=1">
<title>
<![CDATA[
Derivation and validation of clinical prediction models for viral etiologies of acute diarrhea in North American children presenting for emergency care 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.05.14.26353143v1?rss=1
</link>
<description><![CDATA[
Background: Diarrheal illness in children leads to 3.5 million care visits and 200,000 hospitalizations annually in the US. Viruses are responsible for most pediatric diarrheal cases, yet limited guidance on distinguishing viral from bacterial etiologies complicates clinical decision-making, especially regarding empiric antibiotic use. Methods: We used clinical and qualitative molecular etiologic data from the Implementation of Molecular Diagnostics for Pediatric Acute Gastroenteritis (IMPACT) study to develop prediction models for viral etiology of diarrhea. We used conditional random forests to identify informative clinical and environmental predictors and evaluated model performance using logistic regression and random forests within a 5-fold cross-validation framework. We conducted external validation using the Alberta Provincial Pediatric Enteric Infection Team (APPETITE) dataset. Results: Variables predictive of viral etiology included younger age, non-bloody diarrhea, winter season, and presence of vomiting. External validation showed that an AUC of 0.82 can be achieved with a parsimonious 5-variable model, yielding a sensitivity of 0.92 and specificity of 0.55 Conclusion: Our results suggest that in North American healthcare settings, clinical prediction models can inform decision-making by identifying children with a high probability of viral diarrhea, improving diagnostic clarity, and reducing unnecessary testing and treatment.
]]></description>
<dc:creator><![CDATA[ Fonseca-Romero, P., Smith, T., Ahmed, S. M., Jones, A., Alekhina, N., Brintz, B. J., Dien Bard, J., Chapin, K. C., Cohen, D. M., Festekjian, A., Jackson, J. T., Kanwar, N., Larsen, C. D., Leber, A. L., Selvarangan, R., Freedman, S., Pavia, A. T., Leung, D. T. ]]></dc:creator>
<dc:date>2026-05-18</dc:date>
<dc:identifier>doi:10.64898/2026.05.14.26353143</dc:identifier>
<dc:title><![CDATA[Derivation and validation of clinical prediction models for viral etiologies of acute diarrhea in North American children presenting for emergency care]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-05-18</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.05.13.26351511v1?rss=1">
<title>
<![CDATA[
Rental housing may contribute to racial and ethnic disparities in upper respiratory infections 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.05.13.26351511v1?rss=1
</link>
<description><![CDATA[
Objective: Upper respiratory infections (URI) are the major trigger of asthma exacerbations in children with asthma and are more likely to be reported by Black and Mexican American children compared to White children in the US. We aimed to evaluate the extent to which obesity, nicotine exposure, household size, and socioeconomic status (SES) explained this excess URI risk among all children and among children with asthma. Study Design: Data collected on children aged 6-17 years from the National Health and Nutritional Examination Survey (2007-2012) were analyzed using survey weights and a mediation approach. Household SES was analyzed as a cumulative score reflecting income poverty ratio, education, and rental housing. URI was defined as cough, cold, phlegm, runny nose, or other respiratory illness (excluding hay fever and allergies) in the past 7 days. Results: Obesity and serum cotinine, a marker of nicotine exposure, explained little to none of the excess risk of URI while SES explained 36.4% (95% CI=34.1, 38.6) in Black and 28.5% (95% CI=26.7, 30.5) in Mexican American children. Living in rental housing and income poverty ratio<2, explained half (49.6%, 95% CI=46.9-52.3) and 20% (19.7%, 95% CI=18.9-20.5) of the excess URI risk among Black children, respectively. In Mexican American children, rental housing and low educational attainment each explained approximately 15-17% of the excess URI risk. Results were comparable among children with asthma. Conclusions: Markers of poverty, such as rental housing, contributed substantially to the excess risk of URI among Black and Mexican American children, including among those with asthma.
]]></description>
<dc:creator><![CDATA[ Bhavnani, D., Dunphy, P., Wilkinson, M., Haber, A. L., Matsui, E. C. ]]></dc:creator>
<dc:date>2026-05-17</dc:date>
<dc:identifier>doi:10.64898/2026.05.13.26351511</dc:identifier>
<dc:title><![CDATA[Rental housing may contribute to racial and ethnic disparities in upper respiratory infections]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-05-17</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.05.15.26347859v1?rss=1">
<title>
<![CDATA[
Who infected the reported cases? Evidence from 678,482 COVID-19 cases with identified infector collected in routine surveillance in the Netherlands, 2020-2022. 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.05.15.26347859v1?rss=1
</link>
<description><![CDATA[
Background During infectious disease outbreaks, characteristics of reported cases are routinely collected. These give information on becoming infected but not on infecting others. We assess whether linking infectees to infectors, together with their characteristics, can help understand transmission. Methods From the start of the COVID-19 pandemic in the Netherlands, reported cases were asked to identify their most probable infector in routine surveillance, enabling the linking of cases. We assess for the period 27 February 2020 - 11 April 2022 whether the infectees of these transmission pairs are representative of all reported cases, whether the transmission pairs yield verifiable estimates of epidemiological characteristics (here the serial interval), and whether they provide information on transmission that cannot be obtained otherwise. Results Of 8,003,008 reported cases, 678,482 (8.5%) could be linked to their most probable infector. These infectees were largely representative of the reported cases regarding age group, sex, and geographical location. The mean serial interval of 3.6 days (sd 3.4 days) from transmission pairs aligns with literature. Transmissions between age groups largely follow known contact patterns. Most transmissions in September 2021 occurred between persons who were not (fully) vaccinated, indicating the effectiveness of the vaccine, and relatively few between persons with different vaccination status, indicating assortative mixing in vaccination status. Conclusion Transmission pairs can be efficiently collected in routine surveillance, providing insight into disease transmission. The current post-pandemic period provides an excellent opportunity to adjust reporting systems for linking infectees to their most probable infector as preparation for future outbreaks.
]]></description>
<dc:creator><![CDATA[ Backer, J. A., Leung, K. Y., Andeweg, S. P., Van de Kassteele, J., Veldhuijzen, I., Hahne, S., Wallinga, J. ]]></dc:creator>
<dc:date>2026-05-17</dc:date>
<dc:identifier>doi:10.64898/2026.05.15.26347859</dc:identifier>
<dc:title><![CDATA[Who infected the reported cases? Evidence from 678,482 COVID-19 cases with identified infector collected in routine surveillance in the Netherlands, 2020-2022.]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-05-17</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.05.13.26353093v1?rss=1">
<title>
<![CDATA[
Potential limitations of community-wide strategy to treat Mycobacterium tuberculosis infection 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.05.13.26353093v1?rss=1
</link>
<description><![CDATA[
A quarter of the world's population has immunologic evidence of past or present Mycobacterium tuberculosis (Mtb) infection (MTBI) detected as TST or IGRA positivity. Community-based preventive treatment of individuals with MTBI has resulted in transient decreases in TB cases, but its long-term effectiveness has been controversial. Due to the likelihood that many of those with immune responses to Mtb antigens may no longer harbor Mtb, widespread treatment of all such individuals may result in unnecessary exposure to antibiotics. We raise an additional concern that preventive treatment of individuals with MTBI, who are not at the risk of disease progression, may result in loss of protective immunity, provided by the persistent infection, and enhanced risk of TB upon re-exposure to Mtb. There is evidence from human cohorts and animal studies that prior exposure to Mtb confers protection against TB development upon re-exposure, and that treatment of Mtb-infected animals often results in loss of this protection. We build a novel epidemiological model of Mtb dynamics and progression to TB in a community allowing for protection afforded by MTBI against exogenous reinfection-driven disease progression. We show that implementation of treatment of MTBI in the whole community will result in reduction of TB cases but stopping the program may result in an increase in new TB cases that may offset (or even exceed) benefits of the preventive treatment program. Our results suggest that better understanding protective effects provided by MTBI against progression to TB upon Mtb re-exposure and identification of Mtb-infected individuals who most benefit from preventive treatment must be a priority before preventive treatment of asymptomatic MTBI is widely implemented.
]]></description>
<dc:creator><![CDATA[ Batabyal, S., Urdahl, K., Ganusov, V. V. ]]></dc:creator>
<dc:date>2026-05-17</dc:date>
<dc:identifier>doi:10.64898/2026.05.13.26353093</dc:identifier>
<dc:title><![CDATA[Potential limitations of community-wide strategy to treat Mycobacterium tuberculosis infection]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-05-17</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.05.12.26353074v1?rss=1">
<title>
<![CDATA[
Geographic Clustering and Spatial Spillovers of Pediatric Appendicitis Mortality: A 169-Country Spatial Analysis from 2000 to 2019 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.05.12.26353074v1?rss=1
</link>
<description><![CDATA[
Background Appendicitis is a readily treatable surgical emergency, yet it remains a cause of preventable death among children in resource-limited settings. While recent studies have documented the global burden of pediatric appendicitis, none have systematically examined its geographic clustering or spatial spillover effects. Understanding whether high-mortality countries cluster geographically, and whether neighboring countries influence each other's outcomes, is essential for designing regional surgical capacity strategies. Methods We conducted a spatial analysis of pediatric appendicitis case fatality rates in children aged 0-14 years across 169 countries from 2000 to 2019. Data were obtained from the Global Burden of Disease Study 2023 and World Bank databases. We calculated global Moran's I to assess spatial autocorrelation, used Getis-Ord Gi* to identify local hotspots, and fitted spatial lag and spatial error regression models to quantify spatial spillovers while adjusting for GDP per capita, physician density, and basic sanitation access. Results Global Moran's I was 0.621 in 2000 (p < 0.001), 0.621 in 2010 (p < 0.001), and 0.592 in 2019 (p < 0.001), indicating strong and persistent spatial clustering. Hotspots at 99% confidence were consistently concentrated in sub-Saharan Africa and parts of South Asia, with little change in geographic distribution over two decades. The spatial error model provided the best fit (AIC = 212.6), with a spatial error coefficient ({lambda}) of 0.663 (p < 0.001), suggesting that approximately 66% of residual variation was explained by unobserved regional factors. In the final model, higher GDP per capita ({beta} = -0.497, p < 0.001) and higher physician density ({beta} = -0.568, p < 0.001) were independently associated with lower case fatality, while basic sanitation access showed no significant association (p = 0.284). Conclusions Pediatric appendicitis case fatality exhibits strong and persistent geographic clustering. The substantial spatial spillover effect suggests that regional coordination of surgical capacity building may be more effective than country-by-country investments. Priority should be given to hotspot countries in sub-Saharan Africa and South Asia, with emphasis on surgical workforce expansion rather than broad economic development alone.
]]></description>
<dc:creator><![CDATA[ yang, z., Wu, P., Fu, Y., Jiang, B., Huang, L., Zhou, J. ]]></dc:creator>
<dc:date>2026-05-17</dc:date>
<dc:identifier>doi:10.64898/2026.05.12.26353074</dc:identifier>
<dc:title><![CDATA[Geographic Clustering and Spatial Spillovers of Pediatric Appendicitis Mortality: A 169-Country Spatial Analysis from 2000 to 2019]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-05-17</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.05.13.26353146v1?rss=1">
<title>
<![CDATA[
Association Between Purchase of Organic Food and Hypertension Among US Adults: NHANES 2007-2010 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.05.13.26353146v1?rss=1
</link>
<description><![CDATA[
Background: An increasing demand for organic food has risen due to perceived health benefits. Current evidence for the health effects of organic food is limited. Objective: To evaluate the association between organic food purchase as a proxy for organic food consumption and hypertension in a nationally representative population of the US. Methods: This was a cross-sectional study that included 9173 participants aged >= 18 and had available data of both organic food purchase and hypertension from the National Health and Nutrition Examination Survey 2007-2010. Organic food purchase and frequency were obtained from survey questionnaires. Hypertension was defined as having either a systolic BP >= 130 mm Hg/ diastolic BP >= 80 mm Hg, currently taking antihypertensive medication, or self-reported diagnosis of hypertension. We used multivariable logistic regression with sample weights and adjustment of potential confounders to assess associations (adjusted odds ratio [aOR] and 95% confidence intervals [CI]) between organic food purchase and hypertension status. Results: Findings suggest an 11% decrease in odds of hypertension (aOR = 0.89, 95% CI: 0.75-1.06) among organic food purchasers compared to non-purchasers. Lower odds of hypertension were observed across all categories of organic food purchasing frequency, with 13% lower among rarely purchasing organic food (aOR = 0.87, 95% CI: 0.67-1.14), 9% lower (aOR = 0.91, 95% CI: 0.71-1.16) among sometimes purchasing organic food, and 17% lower (aOR = 0.83, 95% CI: 0.55-1.27) among always or mostly purchasing organic food, as compared to those who never purchased organic food. Conclusion: Our findings suggest that organic food purchase, a proxy for organic food consumption, may be associated with lower odds of hypertension. These findings may reflect either the true benefits of organic food consumption, including lower pesticide amounts and higher nutrient content, or the health-seeking behaviors among health-conscious, healthy, and highly educated individuals.
]]></description>
<dc:creator><![CDATA[ Choi, C., Nianogo, R. A., Chen, L., Arah, O. A. ]]></dc:creator>
<dc:date>2026-05-17</dc:date>
<dc:identifier>doi:10.64898/2026.05.13.26353146</dc:identifier>
<dc:title><![CDATA[Association Between Purchase of Organic Food and Hypertension Among US Adults: NHANES 2007-2010]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-05-17</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.05.12.26353059v1?rss=1">
<title>
<![CDATA[
Quantifying and identifying strategies to improve rotavirus vaccine impact in low- and middle-income countries 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.05.12.26353059v1?rss=1
</link>
<description><![CDATA[
BackgroundRobust quantitative evidence on the impact of rotavirus vaccines, their potential benefits in countries without vaccination, and strategies to improve performance in low- and middle-income countries (LMICs) is essential for informing policy decisions aimed at sustaining and expanding vaccination programs.

Methods and FindingsWe used an age-structured compartmental model of rotavirus gastroenteritis (RVGE) transmission that accounts for the natural history of infection to estimate vaccine impact across 112 LMICs. The model incorporates country-specific data on demographics, transmission dynamics, vaccination schedules, coverage levels, and vaccine performance. We simulated multiple scenarios, including the continuation of current vaccination programs, vaccine introduction in countries without programs, the addition of a third dose, scale-up of coverage to 95% in low-coverage settings, and suspension of vaccination. We quantified health impacts by estimating cases, deaths, and disability-adjusted life years (DALYs) averted from 2006 to 2024 and projected over 2025 to 2034 using either no vaccination or the current program as counterfactual. We estimated that rotavirus vaccination averted a median of 268 million RVGE cases (95% uncertainty interval [UI]: 228-306 million), 35 million moderate-to-severe cases (95% UI: 30-38 million), 817 thousand deaths (95% UI: 684-928 thousand), and 53 million DALYs (95% UI: 45-61 million) between 2006 and 2024, resulting from 81 countries with vaccination programs out of 112 LMICs. Using the current vaccination as a baseline, we estimated substantial additional benefits for all strategies, except for suspension, which would increase the RVGE burden over the next 10 years. Scaling up coverage to at least 95% across all 112 LMICs, with countries without the vaccine using the 6/10/14-week schedule, could avert a median of 296 million RVGE cases (95% UI: 243-358 million), 832 thousand deaths (95% UI: 694-932 thousand), and 55 million DALYs (95% UI: 45-61 million), respectively. Furthermore, adding a third dose in the 51 countries currently using a two-dose schedule could enhance vaccine impact, averting a median of 123 million RVGE cases (95% UI: 102-145 million), 377 thousand deaths (95% UI: 310-440 thousand), and 24 million DALYs (95% UI: 20-28 million), respectively, compared to the two-dose schedule.

ConclusionsOur model demonstrates that rotavirus vaccination provides substantial health benefits, with an even greater impact achievable through broader adoption and increased coverage. Adding a third dose to the standard two-dose Rotarix schedule could be an additional strategy to improve vaccine impact in LMICs. These findings support continued efforts to sustain and expand vaccination programs across LMICs. The country-specific, model-estimated rotavirus burden can also inform economic evaluations to guide more effective vaccination strategies.
]]></description>
<dc:creator><![CDATA[ Asare, E. O., Kwon, J., Li, X., Al-Mamun, M. A., Lartey, B. L., Jere, K. C., Cunliffe, N. A., Armah, G. E., Lopman, B., Pitzer, V. E. ]]></dc:creator>
<dc:date>2026-05-15</dc:date>
<dc:identifier>doi:10.64898/2026.05.12.26353059</dc:identifier>
<dc:title><![CDATA[Quantifying and identifying strategies to improve rotavirus vaccine impact in low- and middle-income countries]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-05-15</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.05.12.26352978v1?rss=1">
<title>
<![CDATA[
Self-Rated Health Inequalities Among Registered Nurses: A Cross-Sectional Analysis of UK Longitudinal Studies 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.05.12.26352978v1?rss=1
</link>
<description><![CDATA[
BackgroundHealth inequalities between occupational or social class groups are pervasive and persistent. Healthcare professionals have better health outcomes compared to the general population. Whether this is a result of healthcare education, favourable socio-demographic characteristics among professionals or other effects is not certain and the extent to which single healthcare occupational groups exhibit inequalities is unknown. We have described self-rated health and quantified geographic health inequalities among a single occupational group of Registered Nurses compared to the general population.

MethodsWe analysed nationally representative samples from the 2011 UK Censuses across England, Wales and Scotland in the Office for National Statistics Longitudinal Study and Scottish Longitudinal Study. Self-rated health and socio-demographic characteristics for the study population are described. Inequalities in health by area deprivation among Registered Nurses and the General Population are quantified. Logistic regression analysis was used to assess the association between Nurse status and self-rated health, adjusting for socio-demographic variables.

ResultsAmong economically active, working age adults (n = 478,802), we identified 9,180 Registered Nurses resident in England, Wales and Scotland. 59% of Registered Nurses reported  very good self-rated health, with only 1% reporting  poor or  very poor health. A smaller proportion of Registered Nurses reported less than good health than the General Population at every level of area deprivation and had smaller absolute (4.1 percentage points vs. 9.1) and relative (RR: 1.5 vs. 2.0) inequalities between residents in the most and least deprived areas. Registered Nurses have an increased likelihood of reporting good or better health compared to the general population (Scotland - OR: 1.3, 95% CI: 1.2 - 1.5, England & Wales - OR: 1.4, 95% CI: 1.3 - 1.5) after adjusting for socio-demographic factors.

DiscussionRegistered Nurses report better health compared to the general population and have smaller inequalities in health by area deprivation. However, unfair and avoidable geographical differences in health are present even in this socioeconomically privileged professional group. After adjusting for socioeconomic and demographic factors, the positive association between being a Registered Nurse and having good self-rated health remained.
]]></description>
<dc:creator><![CDATA[ Ball, W. P., Kyle, R. G., Atherton, I. M. ]]></dc:creator>
<dc:date>2026-05-15</dc:date>
<dc:identifier>doi:10.64898/2026.05.12.26352978</dc:identifier>
<dc:title><![CDATA[Self-Rated Health Inequalities Among Registered Nurses: A Cross-Sectional Analysis of UK Longitudinal Studies]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-05-15</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.05.11.26352889v1?rss=1">
<title>
<![CDATA[
From naive to foundation: benchmarking models for epidemic forecasting 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.05.11.26352889v1?rss=1
</link>
<description><![CDATA[
We systematically evaluate and compare the performance of classical statistical methods (ARIMA), mechanistic compartmental models (SEIR), modern deep learning architectures (LSTM, DLinear, Autoformer), and an emerging time-series foundation model (TabPFN-TS) to forecasts the incidence of Influenza-Like Illness (ILI) across nine European countries. The models are benchmarked against a naive baseline and a multi-model ensemble (RespiCast) created by an initiative of the ECDC. In line with the operational practice of existing forecasting hubs, our entire evaluation is explicitly optimized for short-term horizons (1 to 4 weeks ahead). Interestingly, we found that the foundation model TabPFN-TS allows for great zero-shot inference capabilities. Without any task-specific retraining, it successfully overcomes extreme data scarcity to consistently outperform all other individual architectures, frequently rivalling or surpassing the RespiCast ensemble. Our results highlight how deep learning architectures are severely constrained by extreme data scarcity, typical in epidemic forecasting, requiring targeted endogenous data augmentation to reduce predictive errors. Within the deep learning class of models, we observe that simpler architectures (such as DLinear and LSTM) frequently exhibit greater robustness and outperform complex, attention-based models (such as Autoformer) when data is constrained. Finally, our results show how a weighted ensemble, constructed by fusing all the models, delivers highly robust forecasts in all regions considered. Overall, our findings showcase the transformative potential of zero-shot foundation models in epidemic forecasting and confirm the importance of multi-model ensembles.
]]></description>
<dc:creator><![CDATA[ Wang, D., Li, Y., Perra, N. ]]></dc:creator>
<dc:date>2026-05-13</dc:date>
<dc:identifier>doi:10.64898/2026.05.11.26352889</dc:identifier>
<dc:title><![CDATA[From naive to foundation: benchmarking models for epidemic forecasting]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-05-13</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.05.09.26352793v1?rss=1">
<title>
<![CDATA[
Association between remnant cholesterol-to-HDL-C ratio and obstructive sleep apnea risk in U.S. adults: a cross-sectional analysis of NHANES 2015-2018 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.05.09.26352793v1?rss=1
</link>
<description><![CDATA[
BackgroundSeveral lipid ratios have been linked to obstructive sleep apnea (OSA) risk in NHANES, yet two questions central to clinical translation remain unanswered: how much of the association is carried by central adiposity, and whether the dose-response curve contains an actionable threshold. We addressed both for the remnant cholesterol-to-HDL-C ratio (RC/HDL-C).

MethodsWe analysed 3,635 adults aged [&ge;]20 years from NHANES 2015-2018. OSA risk was ascertained from the Sleep Disorders Questionnaire. Multivariable logistic regression estimated odds ratios across three nested models. Restricted cubic splines and segmented regression characterised the dose-response and located the inflection point. Mediation by body roundness index (BRI) was quantified by nonparametric percentile bootstrap (1,000 resamples). Discrimination was compared by ROC analysis, with stratified and trimmed-sample sensitivity analyses.

ResultsOSA risk was identified in 1,361 participants (37.4%). Each one-unit rise in RC/HDL-C carried 23% higher adjusted odds of OSA (OR 1.23, 95% CI 1.03-1.47); the highest quartile carried 49% higher odds than the lowest (P-trend < 0.001). The dose-response was nonlinear, with an inflection at RC/HDL-C = 0.232: below this point each 0.1-unit increase raised odds by 54% (OR 1.54, 95% CI 1.16-2.05); above it the curve plateaued. BRI mediated 82.7% of the total effect (ACME 0.039, P < 0.001), with the indirect pathway 2.8 times stronger in women. AUCs were 0.599 (BRI) and 0.564 (RC/HDL-C).

ConclusionsRC/HDL-C showed a modest, threshold-shaped association with OSA risk in U.S. adults, with central adiposity (BRI) as the predominant mediating factor. These exploratory findings, based on questionnaire-defined OSA, warrant prospective validation in cohorts with polysomnography.
]]></description>
<dc:creator><![CDATA[ Zhu, Z., Shan, S. ]]></dc:creator>
<dc:date>2026-05-13</dc:date>
<dc:identifier>doi:10.64898/2026.05.09.26352793</dc:identifier>
<dc:title><![CDATA[Association between remnant cholesterol-to-HDL-C ratio and obstructive sleep apnea risk in U.S. adults: a cross-sectional analysis of NHANES 2015-2018]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-05-13</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.05.09.26352820v1?rss=1">
<title>
<![CDATA[
Benchmarking foundation models for improving confounding control in target trial emulation 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.05.09.26352820v1?rss=1
</link>
<description><![CDATA[
Machine learning models for causal inference aim to adjust for confounding factors that are associated with both an exposure and an outcome, creating a spurious biased association. But, these methods are rarely empirically evaluated to assess their success in mitigating such bias. Recent advances in knowledge representation, including both foundation models and knowledge graphs, could enrich these models, but rigorous evaluations are needed in order to assess their potential. Here, we ask whether enriching existing causal inference models with knowledge representations from foundation models can improve confounding control. Rather than using semi-simulated data to address this question, we focus on examples of real confounding: we emulate target randomized active comparator trials that are subject to confounding by indication. Our results can guide researchers aiming to develop or apply methods for discovering causal effects from observational data.
]]></description>
<dc:creator><![CDATA[ Kleper, S. L., Melamed, R. D. ]]></dc:creator>
<dc:date>2026-05-13</dc:date>
<dc:identifier>doi:10.64898/2026.05.09.26352820</dc:identifier>
<dc:title><![CDATA[Benchmarking foundation models for improving confounding control in target trial emulation]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-05-13</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.05.08.26352715v1?rss=1">
<title>
<![CDATA[
Early pregnancy metabolomics and risk of offspring heart defects: a matched case-control study 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.05.08.26352715v1?rss=1
</link>
<description><![CDATA[
Congenital heart defects (CHDs) are the most common congenital malformations and often arise from perturbations during early embryonic development. Maternal metabolic disturbances in early pregnancy may contribute to CHD risk, but evidence from early first-trimester metabolomics studies is limited. We conducted an untargeted metabolomics case-control study using early first-trimester maternal plasma samples (gestational weeks 4-10) from the Danish National Birth Cohort. Metabolite profiling was performed via liquid chromatography-tandem mass spectrometry (LC-MS/MS) on 160 matched CHD case-control pairs (320 total samples). Conditional logistic regression and interaction analysis were used to identify metabolites associated with CHD risk or specific cardiac phenotypes. A total of 1,471 metabolite features were measured with 69 metabolites being associated with CHD at nominal significance (p < 0.05). These included a desaturated analog of sphingosine-1-phosphate (S1P), isoleucylproline and an arginine related metabolite. However, after false discovery rate correction for multiple testing no metabolites remained significant. While these findings do not preclude that subtle metabolic variation may exist in early pregnancy among CHD cases, they also underscore the challenges of biomarker discovery in this context. This work highlights the potential of early-pregnancy metabolomics for CHD biomarker discovery, and points toward more targeted future studies with improved sample collection protocols, pre-specified pathway panels, and phenotype-homogeneous analyses to better capture the subtle metabolic variation that may underlie CHD risk.
]]></description>
<dc:creator><![CDATA[ Nastou, K., Ottosson, F. A., Schmidt, A., Corn, G., Geller, F., Grundvad Boelt, S., MacSween, N., Wohlfahrt, J., Lund, M., Melbye, M., Ernst, M., Feenstra, B. ]]></dc:creator>
<dc:date>2026-05-12</dc:date>
<dc:identifier>doi:10.64898/2026.05.08.26352715</dc:identifier>
<dc:title><![CDATA[Early pregnancy metabolomics and risk of offspring heart defects: a matched case-control study]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-05-12</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.05.08.26352137v1?rss=1">
<title>
<![CDATA[
Declining but increasingly concentrated HIV stigma in rural Uganda: population-based cohort study, 2014-2024 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.05.08.26352137v1?rss=1
</link>
<description><![CDATA[
BackgroundHIV-related stigma remains a primary barrier to the elimination of the HIV epidemic worldwide. No studies have examined long-term changes in the distribution of stigmatizing attitudes within populations.

MethodsWe conducted a whole-population, open cohort study of adults in 8 villages in rural southwestern Uganda, with 5 biennial surveys spanning 2014-2024 (N=1,776 at baseline; 869 participated in all waves). We measured individual negative attitudes toward people with HIV ("public stigma") and perceptions of negative attitudes among others ("perceived stigma") using parallel 15-item scales. We estimated mean stigma scores, computed inequality measures at each wave, and decomposed inequality by sociodemographic characteristics. Leveraging the cohort design, we estimated intraclass correlation coefficients and rank-order stability over time.

ResultsBoth public and perceived stigma declined substantially from baseline to endline and became concentrated in an increasingly smaller subgroup of the population. Theil decomposition failed to identify any stratifying variables that explained more than 3% of this variation: nearly all the inequality in HIV stigma occurred within population subgroups rather than between them. In longitudinal analyses, public stigma showed trait-like properties (intraclass correlation coefficient=0.35; 95% CI, 0.31-0.38) and meaningful rank-order stability (baseline-to-endline r=0.41). Perceived stigma showed no rank-order stability, no appreciable between-person variance, and universal convergence to low levels regardless of baseline.

ConclusionsBoth public and perceived HIV stigma declined substantially in this rural Ugandan population, but remaining public stigma has become concentrated within a persistent minority. Sociodemographic profiling to target individuals who carry persistently negative attitudes toward people with HIV is unlikely to succeed.
]]></description>
<dc:creator><![CDATA[ Tsai, A. C., Baguma, C., Ahereza, P., Ashaba, S., Ayebare, P., Bangsberg, D. R., Comfort, A. B., Gumisiriza, P., Juliet, M., Kananura, J., Kiconco, A., Kyokunda, V., Lukwago, P., Mushavi, R. S., Namara, E. B., Perkins, J. M., Rasmussen, J. M., Satinsky, E. N., Siedner, M. J., Tweheyo, B. M., Kakuhikire, B. ]]></dc:creator>
<dc:date>2026-05-12</dc:date>
<dc:identifier>doi:10.64898/2026.05.08.26352137</dc:identifier>
<dc:title><![CDATA[Declining but increasingly concentrated HIV stigma in rural Uganda: population-based cohort study, 2014-2024]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-05-12</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.05.08.26352718v1?rss=1">
<title>
<![CDATA[
Modeling the Impact of Exposed Cases in a Hantavirus Outbreak on a Cruise Ship 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.05.08.26352718v1?rss=1
</link>
<description><![CDATA[
The emergence of a hantavirus variant aboard a commercial cruise ship presents a significant public health concern. This study develops a discrete-time stochastic Susceptible-Exposed-Infectious-Recovered-Dead model to estimate transmission dynamics, hidden exposed infections, and outbreak risk among passengers and crew. Epidemiological parameters and latent disease states were inferred using an Ensemble Adjustment Kalman Filter calibrated to reported case data from WHO and ECDC situation reports. The estimated basic reproduction number was 2.76, with a 95% confidence interval of 2.52-2.99, indicating substantial potential for sustained onboard transmission before strict quarantine measures. Simulations further suggest that several exposed individuals may remain unidentified during the early outbreak phase, creating a hidden reservoir that symptom-based surveillance alone may fail to detect. These findings highlight the importance of rapid surveillance, widespread testing, targeted quarantine, and active monitoring of exposed individuals in confined travel settings. The proposed modeling framework can support timely outbreak assessment and intervention planning for infectious-disease events in similarly dense and spatially constrained populations.
]]></description>
<dc:creator><![CDATA[ Cui, J. ]]></dc:creator>
<dc:date>2026-05-12</dc:date>
<dc:identifier>doi:10.64898/2026.05.08.26352718</dc:identifier>
<dc:title><![CDATA[Modeling the Impact of Exposed Cases in a Hantavirus Outbreak on a Cruise Ship]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-05-12</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.05.08.26352733v1?rss=1">
<title>
<![CDATA[
Canine Rabies in NDjamena: A Metapopulation SEIR Model Incorporating Vaccination and Inter-Patch Distances 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.05.08.26352733v1?rss=1
</link>
<description><![CDATA[
Canine rabies persists in NDjamena (Chad) despite vaccination campaigns exceeding 70% coverage, suggesting a role for dog mobility and spatial heterogeneity. We propose a metapopulation SEIR model incorporating distance-modulated dog movements and an explicit vaccinated class. Analysis of the isolated patch establishes global stability of the disease-free equilibrium via a Lyapunov function. For the metapopulation, a composite Lyapunov function shows that elimination is governed by a reproduction number [R]v. Calibrated with field data (2012-2022), simulations reveal that uniform vaccination of both patches reduces [R]v by 46% (from 2.84 to 1.52) but does not achieve elimination, while targeted strategies are less effective. These results demonstrate that exhaustive vaccination coverage across the entire urban network and increased vaccination intensity are necessary to eliminate canine rabies in NDjamena. Our model provides a quantitative framework for planning effective control strategies.
]]></description>
<dc:creator><![CDATA[ Djimramadji, H., Koutou, O., Dawe, S. ]]></dc:creator>
<dc:date>2026-05-12</dc:date>
<dc:identifier>doi:10.64898/2026.05.08.26352733</dc:identifier>
<dc:title><![CDATA[Canine Rabies in NDjamena: A Metapopulation SEIR Model Incorporating Vaccination and Inter-Patch Distances]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-05-12</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.05.08.26352755v1?rss=1">
<title>
<![CDATA[
Source Matters: An Examination of Drug Checking Samples from Police Departments and Community Based Programs in Massachusetts 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.05.08.26352755v1?rss=1
</link>
<description><![CDATA[
Aims and SettingIn the U.S., the emergence of new adulterants and novel psychoactive substances continues to complicate approaches to overdose, treatment, and public safety. Information about this changing drug supply is often gleaned from police drug seizures, but community drug checking services, which test the contents of a persons drug supply and share that data, provide another means to understand local drug supplies. However, it is unclear how seized drugs differ from those collected in the community, whether one approach is potentially more instructive, and what can be learned about local drug supplies from each source. We therefore compared drug samples tested from police departments (PDs) and community partner (CP) drug checking programs to examine what, if any, differences existed in sample content, form, submitter characteristics, and emerging substance presence.

DesignWe conducted a retrospective cohort analysis of drug samples collected and tested between April 2018 and December 2025 by the Massachusetts Drug Supply DataStream derived from CPs and PDs operating in the same geographic area across eight locations. Bivariate analyses (Chi-square, Fishers exact) tested for differences in sample and submitter characteristics by source.

FindingsThere were 2,430 unique samples submitted by CPs (68.1%) and PDs (31.9%) from the same location. Compared to CP samples, proportionally more PD samples showed fentanyl as primary substance (74.2% PD vs. 64% CP, p<.001) and less often contained additives (xylazine 15.0% PD vs. 27.4% CP; medetomidine 0.6% PD vs. 2.2% CP, both p<.001). PD samples were typically powders (73.2% vs. 37.9%) and pills (13.6% vs. 3.6%) while CP samples were more often residue (51.9% vs. 2.1%, p<.001). Submitter characteristics, when reported, differed by source: gender (n=528, male: 78.6% PD vs. 50.1% CP, p<.001), race/ethnicity (n=468, Black: 15.8% PD vs. 7.8% CP; Hispanic: 6.7% PD vs. 13.2% CP, p<.05), and associated overdose (n=242, fatal: 62.9% vs. 10.9%, p<.001). Emergent substances were detected a median of 249 days sooner in CP than co-located PD samples, though drugs exhibiting concerning patterns (e.g., unexpected fentanyl in stimulants) had similar, swift detection times.

ConclusionDrug samples differ based on PD vs. CP source in significant ways that may introduce bias when drawing conclusions about drug supply trends but also offer unique insights for public health and responses to emerging drugs. Modern drug monitoring should include a broad range of sources to best prepare for changes the illicit supply may bring to overdose prevention, public safety, and health systems.
]]></description>
<dc:creator><![CDATA[ Silcox, J., Rapisarda, S., Chase, E., Huntington, N., Raeke, S., Consigli, A., Del Pozo, B., Green, T. C. ]]></dc:creator>
<dc:date>2026-05-12</dc:date>
<dc:identifier>doi:10.64898/2026.05.08.26352755</dc:identifier>
<dc:title><![CDATA[Source Matters: An Examination of Drug Checking Samples from Police Departments and Community Based Programs in Massachusetts]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-05-12</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.05.08.26352721v1?rss=1">
<title>
<![CDATA[
The covariance matrix of metapopulation disease models and applications to early warning signals 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.05.08.26352721v1?rss=1
</link>
<description><![CDATA[
Infectious disease time series often show signs of epidemic transitions, such as the peaks and troughs of the time series. In these time series, key system parameters can lead to catastrophic changes in the dynamical system behaviour (often called critical transitions). Modellers have increasingly shown that early warning signals can anticipate these transitions, both critical and non-critical, in infectious disease time series. Existing methods, however, generally focus on univariate time series data, or ignore spatiotemporal patterns that may be present as a disease spreads through a population. Recent ecological literature developments expand existing temporal and spatial methods to consider the covariance matrix of multiple, related time series. However, many of these proposed signals still make an assumption of stationary time series/system equilibrium. Whilst often true in ecological modelling, disease systems are seldom at equilibrium. In this paper, we propose the usage of the eigendecomposition of the non-stationary covariance matrix as a more suitable early warning signal for epidemiological data. We first analyse the expected trends in the eigenvalues and eigenbasis of the covariance matrix on approach to a transition. Next we apply these methods to a spatially-structured susceptible-infectious-recovered model to explore how the eigenbasis may provide extra information to modellers. Finally, we test these methods on SARS-CoV-2 case data during the 2020-2021 pandemic period in England.
]]></description>
<dc:creator><![CDATA[ Looker, J., Rock, K. S., Dyson, L. ]]></dc:creator>
<dc:date>2026-05-12</dc:date>
<dc:identifier>doi:10.64898/2026.05.08.26352721</dc:identifier>
<dc:title><![CDATA[The covariance matrix of metapopulation disease models and applications to early warning signals]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-05-12</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.05.06.26352603v1?rss=1">
<title>
<![CDATA[
SEIR-IoT cyber-physical architecture with dual parametric coupling for epidemic scenario simulation using synthetic biomedical signals 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.05.06.26352603v1?rss=1
</link>
<description><![CDATA[
This study presents a proof-of-concept cyber-physical architecture integrating a SEIR epidemiological model (Susceptible-Exposed-Infectious-Recovered), implemented in MATLAB, with a simulated Internet of Things (IoT) acquisition and transmission stage based on the ESP32 microcontroller and the ThingSpeak platform. The system generates synthetic biomedical signals of body temperature and peripheral oxygen saturation (SpO2), structured across three levels: circadian variation, scheduled pathological episodes, and Gaussian noise. These signals feed a dual parametric coupling function that dynamically updates the SEIR transmission parameter as a combined function of body temperature and oxygen saturation deviations from their clinical reference values. The proposed architecture is organized into four functional phases: measurement, communication, computational processing, and feedback. Five simulated clinical scenarios were evaluated, ranging from normal conditions (T = 36.5 {degrees}C, SpO2 = 97%) to fever with severe hypoxia (T = 38.5 {degrees}C, SpO2 = 88%), yielding basic reproduction number (R0) values between 4.20 and 5.38, and peak infected proportions between 29.9% and 35.2% of the simulated population (N = 1,000). A sensitivity analysis on the coupling coefficients, with {+/-}50% variation from nominal values, showed that the oxygen saturation coefficient is the most influential parameter on R0 (range = 0.76) compared to the thermal coefficient (range = 0.42), with monotonic and predictable behavior across the entire evaluated parametric space. The primary contribution of this work is system integration: we propose a reproducible platform connecting biomedical simulation, IoT communication, and epidemiological modeling through parametric coupling in a controlled environment. All data used are entirely synthetic; a retrospective calibration with real Colombian data from the first epidemic wave of 2020 confirmed the epidemiological consistency of the model, with a calibrated R0 of 1.85 and a Pearson correlation of 0.930. Results should be interpreted as evidence of architectural feasibility, not as clinical or epidemiological validation.

Author SummaryThe COVID-19 pandemic made it clear that epidemiological surveillance systems need tools that combine accessible technology with mathematical models capable of anticipating disease spread. In this work, we built a proof-of-concept platform connecting three elements: a low-cost electronic sensor based on the ESP32 microcontroller, a cloud communication platform (ThingSpeak), and a mathematical model that simulates how an epidemic spreads through a population. The sensor generates synthetic data on body temperature and oxygen saturation that, through a mathematical formula we designed, dynamically modify the rate of contagion in the model. We evaluated five clinical scenarios, ranging from normal conditions to fever with severe hypoxia, and analyzed how sensitive the results are to changes in the system parameters. We found that oxygen saturation has a greater influence on the estimated contagion potential than body temperature. Although all data are synthetic, this platform demonstrates that it is possible to integrate low-cost sensors with epidemiological models in real time, opening a viable pathway for early warning systems in resource-limited settings.
]]></description>
<dc:creator><![CDATA[ Martinez Campo, S. D., Campo-Ariza, F. M., Martinez Campo, J. A., Cormane, M. ]]></dc:creator>
<dc:date>2026-05-10</dc:date>
<dc:identifier>doi:10.64898/2026.05.06.26352603</dc:identifier>
<dc:title><![CDATA[SEIR-IoT cyber-physical architecture with dual parametric coupling for epidemic scenario simulation using synthetic biomedical signals]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-05-10</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.05.06.26352614v1?rss=1">
<title>
<![CDATA[
Outdoor attractive targeted sugar bait Phase III trials for malaria control in Kenya, Mali, and Zambia: An individual participant data meta-analysis 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.05.06.26352614v1?rss=1
</link>
<description><![CDATA[
Attractive targeted sugar baits (ATSB) are a potential new class of vector control tool that act through an "attract and kill" mechanism on mosquitoes. We conducted a meta-analysis using data from three large-scale Phase III trials of the Westham Sarabi v1.2 ATSB (0.11% dinotefuran) conducted in Kenya, Mali, and Zambia, to determine the effect of the intervention on clinical malaria incidence in children, Plasmodium falciparum infection prevalence, and dominant vector species parity, abundance, landing rate, and sporozoite positivity. The Sarabi ATSB was deployed on exterior walls at the rate of two per residential structure. Aggregated and individual-level meta-analyses were completed for each of the six trial outcomes, comprising 6981 person-years of follow-up for clinical malaria incidence (primary epidemiological outcome) and 19443 Anopheles for parity assessment (primary entomological outcome). Post-hoc analyses included assessment of dose-response relationships between coverage-adjusted intervention density and clinical malaria incidence. There were no statistically significant differences between arms in any of the epidemiological or entomological outcomes. There was statistically significant evidence of a 19% reduction in clinical malaria incidence for every 10 bait stations per hectare increase observed in spatial density (IRR 0.81, 95% CI 0.74-0.89, p<0.001), provided that the ATSB were in good condition. This finding suggests that there may be deployment approaches or dosing strategies under which ATSB tools could be efficacious, although threshold spatial densities could not be determined from available data. This meta-analysis furthermore highlights important recommendations for future cluster-randomized trials of vector control interventions, including conducting comprehensive baseline data collection to identify cluster outliers or sites with differences in vector bionomics, and collecting a limited set of entomological outcomes in all trial clusters to ensure an adequately powered and balanced analysis of entomological effects.
]]></description>
<dc:creator><![CDATA[ Ashton, R., McDermott, D. P., Kane, F., Sarrassat, S., Harris, A., Fornadel, C., Wagman, J., Chanda, J., Littrell, M., ter Kuile, F. O., Samuels, A. M., Ochomo, E., Churcher, T. S., Biggs, J., Staedke, S. G., Doumbia, S., Kleinschmidt, I., Yukich, J., Eisele, T. P. ]]></dc:creator>
<dc:date>2026-05-10</dc:date>
<dc:identifier>doi:10.64898/2026.05.06.26352614</dc:identifier>
<dc:title><![CDATA[Outdoor attractive targeted sugar bait Phase III trials for malaria control in Kenya, Mali, and Zambia: An individual participant data meta-analysis]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-05-10</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.05.07.26352639v1?rss=1">
<title>
<![CDATA[
SARS CoV 2 Associated Shifts in the Upper Respiratory Tract Mycobiome in Non Hospitalized Cases 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.05.07.26352639v1?rss=1
</link>
<description><![CDATA[
SARS{square}CoV{square}2 infection is associated with marked changes of the upper respiratory tract mycobiome. URT mycobiome Changes in non-hospitalized patients however, remains poorly defined. We performed shotgun metagenomic sequencing of 95 upper respiratory tract swab samples from 48 symptomatic SARS{square}CoV{square}2-positive individuals and 47 healthy controls from central India. Fungal diversity and community structure were compared using alpha- and beta-diversity analyses, while differential taxa were identified using prevalence-based testing and LEfSe. SARS{square}CoV{square}2-positive samples showed significantly higher fungal alpha diversity than controls, with increased Shannon diversity (p = 0.000319) and Simpson diversity (p = 0.017). Beta-diversity analysis showed significant separation between groups for both Bray-Curtis and Jaccard distances (PERMANOVA p = 0.001), with significant dispersion effects as well (PERMDISP p = 0.001). Differential analysis identified more SARS{square}CoV{square}2-enriched than control-enriched taxa, including Candida orthopsilosis, Malassezia furfur, M. sympodialis, M. globosa, Aspergillus niger, A. terreus, and A. nidulans. Aspergillus sydowii was the main control-enriched taxon. LEfSe and concordant multi-test analysis supported these findings, and sensitivity analysis confirmed robustness across thresholds. Certain SARS{square}CoV{square}2-enriched taxa were linked to confirmed or probable COVID{square}19-associated fungal infections, whereas no such pathogens were detected in controls. These findings indicate that SARS{square}CoV{square}2 infection is associated with URT mycobiome dysbiosis and enrichment of clinically relevant opportunistic fungi in community cases.
]]></description>
<dc:creator><![CDATA[ Tomar, S. S., Khairnar, K. ]]></dc:creator>
<dc:date>2026-05-10</dc:date>
<dc:identifier>doi:10.64898/2026.05.07.26352639</dc:identifier>
<dc:title><![CDATA[SARS CoV 2 Associated Shifts in the Upper Respiratory Tract Mycobiome in Non Hospitalized Cases]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-05-10</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.05.07.26352695v1?rss=1">
<title>
<![CDATA[
Psychosocial mediators for the impact of personal genomic risk information on melanoma prevention and early detection behaviors 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.05.07.26352695v1?rss=1
</link>
<description><![CDATA[
BackgroundIn the Melanoma Genomics Managing Your Risk Study, access to personal genomic risk testing led to improvements in some melanoma prevention and early detection behaviors.

PurposeWe aimed to examine the hypothesized psychosocial mediators of the effects observed in the trial.

MethodsAustralians of European ancestry without melanoma and aged 18-69 years were recruited via the national Medicare database and randomized to receive personal genomic risk information or usual care (N=1,025). Questionnaires were administered at baseline, 1-month post-intervention, and 12-months post-baseline to assess self-reported prevention and early detection behaviors and psychosocial measures. To identify potential mediators, we first evaluated the interventions effect on psychosocial measures and the associations between psychosocial measures and behavioral outcomes. We then estimated the natural indirect effects (NIEs) and their 95% confidence intervals (CIs) to quantify the effects mediated by potential mediators identified.

ResultsAmong participants with high traditional melanoma risk, the interventions effect on increased sun protection at 1-month was partially mediated by changes in perceived importance [NIE mean difference (95% CI): 0.02 (0.00, 0.04)] and perceived effectiveness [0.01 (0.00, 0.03)] of sun protection strategies. Among women, the interventions effect on increased whole-body skin examinations at 1-month was partially mediated by perceived capability to engage in skin examinations [NIE odds ratio (95% CI): 1.08 (1.00, 1.29)] and perceived control over detecting a future melanoma [1.13 (1.03, 1.32)].

ConclusionsThe effectiveness of precision prevention and early detection interventions may be enhanced by targeting key psychosocial mediators through tailored communication of personal melanoma risk.
]]></description>
<dc:creator><![CDATA[ Wang, S. E., Espinoza, D., Lo, S., Smit, A. K., Cust, A. E. ]]></dc:creator>
<dc:date>2026-05-10</dc:date>
<dc:identifier>doi:10.64898/2026.05.07.26352695</dc:identifier>
<dc:title><![CDATA[Psychosocial mediators for the impact of personal genomic risk information on melanoma prevention and early detection behaviors]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-05-10</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.05.04.26352208v1?rss=1">
<title>
<![CDATA[
Decoding the diet-gut-liver axis: links between dietary pattern adherence, gut microbiome, and hepatic health 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.05.04.26352208v1?rss=1
</link>
<description><![CDATA[
Metabolic dysfunction-associated steatotic liver disease (MASLD) is rapidly becoming the leading cause of chronic liver disease and confers substantial cardiometabolic burden. Diet quality and gut microbiota composition have been implicated in MASLD development; however, the interplay among diet, gut microbiota, and hepatic health remains insufficiently characterized. Here, in 9,616 deeply phenotyped middle-aged participants (mean age 52 years) from the Human Phenotype Project, we investigated how five dietary quality indices capturing complementary dimensions of healthy eating, including plant-based (hPDI), Mediterranean-style (AMED), anti-inflammatory (rDII), anti-hyperinsulinemic (rEDIH), and overall quality (AHEI), relate to gut microbial composition and liver steatosis. Dietary pattern scores were derived from two-week continuous diet logs, gut microbiota was characterized by shotgun metagenomic sequencing, and hepatic health was assessed by both ultrasound-derived metrics and prevalent MASLD status. Adherence to each of the five healthy dietary patterns was inversely associated with MASLD prevalence and positively associated with liver speed of sound (SoS), an ultrasound-derived metric that correlates inversely with hepatic fat content. Across all five dietary patterns, greater adherence was consistently associated with 138 gut microbial species, including inverse associations with Flavonifractor plautii, Dysosmobacter welbionis, Ruthenibacterium lactatiformans, Bilophila wadsworthia, and Phocea massiliensis. These five species were also associated with lower liver SoS and higher odds of prevalent MASLD, emerging as potential mediators of the diet-liver relationship in cross-sectional mediation analyses after adjustment for body mass index (BMI). This study identifies candidate microbial targets for future interventional studies investigating dietary strategies for MASLD prevention.
]]></description>
<dc:creator><![CDATA[ Deng, K., Ducarmon, Q. R., Godneva, A., Zhang, Z., Hylckama Vlieg, A. v., Rosendaal, F. R., Zeller, G., Segal, E., Li-Gao, R., DIYUFOOD consortium ]]></dc:creator>
<dc:date>2026-05-10</dc:date>
<dc:identifier>doi:10.64898/2026.05.04.26352208</dc:identifier>
<dc:title><![CDATA[Decoding the diet-gut-liver axis: links between dietary pattern adherence, gut microbiome, and hepatic health]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-05-10</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.05.06.26352609v1?rss=1">
<title>
<![CDATA[
Retinal Vasculature, Plasma Metabolites and Cardiovascular Disease Risk: A Prospective Cohort Study from the Canadian Longitudinal Study on Aging 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.05.06.26352609v1?rss=1
</link>
<description><![CDATA[
BackgroundThis study aimed to investigate whether retinal fractal dimension (Df), a measure of microvascular branching complexity from fundus images, together with plasma metabolites, can help identify pathways linking microvascular changes to cardiovascular disease (CVD) events.

MethodsWe analyzed longitudinal data from a subset of 4,781 participants from the Comprehensive cohort of the Canadian Longitudinal Study on Aging (CLSA), free of CVD at baseline (mean age 58.74 {+/-} 8.39; 47% male), and with 811 plasma metabolites measured at baseline and retinal imaging. Total, arterial and venular Df were derived from fundus photographs using the Vessel Assessment and Measurement Platform for Images of the Retina. Incident CVD was defined as one or more of self-reported physician-diagnosed myocardial infarction, angina, coronary heart disease, stroke, transient ischemic attack, or peripheral vascular disease during follow-up. Regression models tested associations among Df, plasma metabolites and incident CVD.

ResultsOver a median follow-up of 5.75 years (IQR 5.48-6.04), 546 participants (11.42%) developed CVD. Higher total, arterial and venular Df were associated with lower CVD risk in unadjusted analyses (Odds Ratio (OR)=0.62, 95% CI:0.53-0.72 for total Df; OR=0.78, 95% CI:0.70-0.86 for arterial Df; OR=0.74, 95% CI:0.67-0.82 for venular Df). Total Df demonstrated the strongest predictive value for incident CVD but not independently of established CVD risk factors. Nine plasma metabolites, including amino acids, lipids, and xenobiotics, were associated with both incident CVD and one Df measure (p < 0.05), with cotinine and hydroxycotinine satisfying a false discovery rate adjustment (q < 0.05). Consistent with these findings the Total Nicotine Equivalent (TNE-3) was also associated with both lower arterial Df and increased CVD risk.

ConclusionsRetinal microvascular complexity is associated with incident CVD. Nicotine metabolism from tobacco smoking exposures emerged as the strongest association linking microvascular changes and CVD events.

Clinical PerspectiveO_ST_ABSWhat is New?C_ST_ABSO_LILower retinal branching complexity, as measured through Df, is significantly associated with incident cardiovascular disease (CVD) in unadjusted analyses.
C_LIO_LIIn a population-based sample, we found nine plasma metabolites associated with both retinal vascular complexity and incident CVD, but only nicotine metabolites were significant after multiple testing correction.
C_LIO_LINicotine metabolites, particularly cotinine and hydroxycotinine, remained significantly associated with incident CVD even after adjustment for self-reported smoking status.
C_LI

What Are the Clinical Implications?O_LIRetinal Df measures could be used as a predictor of CVD event, although not independently of age and traditional cardiovascular risk factors.
C_LIO_LIMicrovascular changes may lie on the pathway linking nicotine metabolites to CVD events.
C_LIO_LIPlasma nicotine metabolites may provide additional cardiovascular risk information beyond self-reported smoking, reflecting individual exposure, metabolism and passive smoke exposure.
C_LI
]]></description>
<dc:creator><![CDATA[ Indzhova, S. I., Britz-McKibbin, P., Rafiq, T., Joshi, D., Trucco, E., Mannan, F., Azab, S. M., Chong, M., Pigeyre, M. ]]></dc:creator>
<dc:date>2026-05-10</dc:date>
<dc:identifier>doi:10.64898/2026.05.06.26352609</dc:identifier>
<dc:title><![CDATA[Retinal Vasculature, Plasma Metabolites and Cardiovascular Disease Risk: A Prospective Cohort Study from the Canadian Longitudinal Study on Aging]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-05-10</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.05.06.26352579v1?rss=1">
<title>
<![CDATA[
Biomarker Panel Selection Explains Heterogeneity in Allostatic Load-Mortality Risk: A Specification-Curve Analysis 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.05.06.26352579v1?rss=1
</link>
<description><![CDATA[
The allostatic load (AL)-mortality association is well-established, yet published studies use at least 18 distinct calculation methods across 26 biomarkers, raising a fundamental question: does this association reflect a stable biological signal or an artifact of investigator choice? We applied the first multiverse specification-curve analysis of AL to two independent NHANES cohorts (NHANES III: n = 17,285; NHANES 2007-2010: n = 12,729) linked to the National Death Index through 2019, constructing 450 analytical specifications by systematically varying biomarker panel, scoring method, covariate configuration, and mortality outcome. Every cardiovascular mortality specification (100% of 150) and 93.3% of all-cause specifications produced statistically significant hazard ratios exceeding 1.0. Median HRs per 1-SD increment in AL were 1.22 (all-cause, pooled) and 1.36 (cardiovascular) -- numerically identical to Parker et al.s conventional meta-analytic estimate of 1.22. Biomarker panel composition explained 46% of between-specification variance, compared with 4% for covariate adjustment. A five-biomarker panel (SBP, BMI, HDL, HbA1c, creatinine) performed comparably to an 18-biomarker expanded panel, with 100% of specifications significant across both cohorts. The AL-mortality association is a robust biological signal; biomarker panel selection -- not covariate adjustment -- is the primary target for field-wide standardization.
]]></description>
<dc:creator><![CDATA[ Patel, P. C. ]]></dc:creator>
<dc:date>2026-05-08</dc:date>
<dc:identifier>doi:10.64898/2026.05.06.26352579</dc:identifier>
<dc:title><![CDATA[Biomarker Panel Selection Explains Heterogeneity in Allostatic Load-Mortality Risk: A Specification-Curve Analysis]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-05-08</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.05.07.26352661v1?rss=1">
<title>
<![CDATA[
Simpler is not always better: Phylodynamic misspecification and deep-learning corrections 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.05.07.26352661v1?rss=1
</link>
<description><![CDATA[
Phylodynamics bridges the gap between epidemiology and pathogen genetic data by estimating epidemiological parameters from time-scaled pathogen phylogenies. Multi-type birth-death (MTBD) models are phylodynamic analogies of compartmental models in classical epidemiology. They serve to infer the average number of secondary infections R and the infection duration d. Moreover, more complex MTBD models add extra parameters, such as the average length of the incubation period or the proportion of superspreaders in the infected population.

However, these additional parameters come at an important computational cost: Apart from the simplest, BD, model, MTBD models do not have a closed-form solution and require numerical methods for their likelihood computation. This leads to increased computational times and potential numerical errors. Therefore, the BD model remains the favorite researchers choice for real dataset analyses, and is often applied even in cases where more complex epidemiological aspects are present.

We investigated, using simulations, how model misspecification influences inference of R and d in the phylodynamic framework. We showed that the use of models not accounting for various epidemiological aspects leads to bias. In particular the simplest, BD, estimator tends to underestimate R in the presence of super-spreading or incubation, which might be dangerous from the public health prospective. However, deep-learning-based estimators for complex models, which account for multiple epidemiological factors, perform well both on the data where those factors are present and where they are absent. This advocates for the use of complex epidemiologically realistic estimators, whose design has recently become possible thanks to deep learning.
]]></description>
<dc:creator><![CDATA[ XIE, R., Gascuel, O., ZHUKOVA, A. ]]></dc:creator>
<dc:date>2026-05-08</dc:date>
<dc:identifier>doi:10.64898/2026.05.07.26352661</dc:identifier>
<dc:title><![CDATA[Simpler is not always better: Phylodynamic misspecification and deep-learning corrections]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-05-08</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.05.07.26352530v1?rss=1">
<title>
<![CDATA[
A literature scanning and prioritization framework to guide future systematic reviews for World Cancer Research Fund International's Global Cancer Update Programme 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.05.07.26352530v1?rss=1
</link>
<description><![CDATA[
BackgroundThe 2018 World Cancer Research Fund (WCRF)/American Institute for Cancer Research Third Expert Report (TER) on diet, adiposity, physical activity and risk of 19 cancers could be enhanced with new data. A framework is needed to prioritize future systematic reviews.

MethodsWe searched PubMed (January 2019-February 2024) for meta-analyses, pooled analyses, randomized controlled trials (RCTs), Mendelian randomization (MR) studies, and large (>100,000 participants) cohort studies. We assessed TER findings using conditional power (CP) and fail-safe number (FSN) statistics. We developed an exposure-based prioritization score (PS) by awarding or subtracting points considering the quantity, statistical significance, direction, and novelty of associations.

ResultsWe compared 366 meta-analyses, 121 pooled analyses, 19 RCTs, 174 MR studies, and 391 cohort studies covering 151 exposures and 28 cancers with 1,371 TER meta-analyses. Based on CP, non-significant TER associations likely to become significant with additional evidence included folate and colorectal, waist circumference and lung, total fat and ovarian, tea and ovarian, and red meat and kidney cancers. The FSN indicated that most significant TER associations are unlikely to change with additional evidence. The median PS was 6 (range: -15 to 163), with top scores observed for anthropometric measurements (PSheight=40 to PSBMI=163), physical activity (PS=100), sedentary behavior (PS=64), alcohol (PS=52), tea (PS=36), dietary fiber (PS=31), milk/dairy (PS=29), micronutrients (PSretinol=27 to PSiron=38), vitamins (PSB12=22 to PSvitD=91), soy (PS=24), isoflavones (PS=23), and sugar-sweetened beverages (PS=22).

Conclusions and ImpactThe prioritization framework can help identify impactful systematic reviews to complement TER conclusions and enhance our understanding of emerging research.
]]></description>
<dc:creator><![CDATA[ Markozannes, G., Jayedi, A., Cividini, S., Kazmi, S. Z., Cariolou, M., Vieira, R., Pagkalidou, E., Kiss, S., Balducci, K., Aune, D., Gunter, M. J., Cross, A. J., Chan, D. S. M., Tsilidis, K. K. ]]></dc:creator>
<dc:date>2026-05-08</dc:date>
<dc:identifier>doi:10.64898/2026.05.07.26352530</dc:identifier>
<dc:title><![CDATA[A literature scanning and prioritization framework to guide future systematic reviews for World Cancer Research Fund International's Global Cancer Update Programme]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-05-08</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.05.06.26352545v1?rss=1">
<title>
<![CDATA[
Longitudinal cross-species transmission of microbiomes and resistomes across farmers, animals and environment 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.05.06.26352545v1?rss=1
</link>
<description><![CDATA[
Understanding the acquisition and dissemination of microbiomes and antimicrobial resistance genes (ARGs) that circulate across human-animal-environment interfaces remains a central One Health challenge, largely because of complex ecological interactions and multiple confounding factors. Although occupational exposure is known to influence the microbiomes and resistomes of farmers, how environmental compartments involve in this system is unclear. Here, we conducted a one-year longitudinal study combining strain-resolved metagenomics (500 metagenomes) with isolate-based whole-genome sequencing (28 isolates) in an ecologically managed, antibiotic-free farming ecosystem spanning animals, farmers, environmental compartments and non-exposed individuals. Assembling 6,075 species-level genomes, we show that animal-associated occupancy reshapes the microbiome and resistome of occupationally exposed farmers and their surrounding environments. Animals and their associated habitats formed the dominant interface for both strain sharing and ARG dissemination across connected ecological compartments, whereas village residents and surrounding river samples - used as ecological controls - showed limited integration into this sharing network. Tracking a frequently shared lineage further revealed within-lineage genetic turnover together with selection-consistent changes following cross-species spread, suggestive of ecological selection across hosts and habitats. Finally, we identify Klebsiella pneumoniae as the most widespread ESKAPE pathogen in this ecosystem, with repeated occurrence across animal, human and environmental compartments, consistent with a neglected but clinically critical broad profile of ecological generalist. Together, these findings identify animals as central interfaces for microbiome and resistome sharing and show how agricultural ecosystems can sustain circulation of opportunistic pathogens and resistance determinants across human-animal-environment interfaces even in the absence of routine antibiotic use.
]]></description>
<dc:creator><![CDATA[ Xing, J., Xu, Z., Zhang, Y., Zhang, H., Zheng, L., Zhang, M., Guo, W., Liu, J., Pan, Y., Zhang, J., Jie, Z., Baele, G., Li, C., D'Souza, A., Zhao, J., Li, J., Chen, T., Wu, H. ]]></dc:creator>
<dc:date>2026-05-07</dc:date>
<dc:identifier>doi:10.64898/2026.05.06.26352545</dc:identifier>
<dc:title><![CDATA[Longitudinal cross-species transmission of microbiomes and resistomes across farmers, animals and environment]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-05-07</prism:publicationDate>
<prism:section></prism:section>
</item>
</rdf:RDF>
